Dashboard
Manage Tickers

RXSTRxSight, Inc.

Nasdaq rxsight.com


$ 60.62 $ -1.61 (-2.59 %)    

Wednesday, 08-May-2024 13:20:12 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 439.32 $ -1.00 (-0.23 %)
DIA $ 389.59 $ 0.85 (0.22 %)
SPY $ 516.39 $ 1.13 (0.22 %)
TLT $ 90.34 $ 0.03 (0.03 %)
GLD $ 214.20 $ 0.58 (0.27 %)
$ 62.19
$ 62.23
$ 0.00 x 0
$ 62.63 x 100
$ 60.38 - $ 62.96
$ 18.35 - $ 66.54
605,479
na
2.29B
$ 1.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-06-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-08-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 09-09-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wells-fargo-maintains-overweight-on-rxsight-raises-price-target-to-68
Wells Fargo Maintains Overweight on RxSigh...
05/07/2024 16:01:21

Wells Fargo analyst Larry Biegelsen maintains RxSight (NASDAQ:RXST) with a Overweight and raises the price target from $61 t...

what-10-analyst-ratings-have-to-say-about-rxsight
What 10 Analyst Ratings Have To Say About ...
05/07/2024 14:00:17

rxsight-shares-are-trading-higher-after-the-company-reported-better-than-expected-q1-financial-results-and-raised-its-fy24-revenue-guidance-above-estimates-also-multiple-firms-raised-their-respective-price-targets-on-the-stock
RxSight shares are trading higher after th...
05/07/2024 12:44:22

oppenheimer-maintains-outperform-on-rxsight-raises-price-target-to-72
Oppenheimer Maintains Outperform on RxSigh...
05/07/2024 12:40:34

Oppenheimer analyst Steven Lichtman maintains RxSight (NASDAQ:RXST) with a Outperform and raises the price target from $61 t...

needham-maintains-buy-on-rxsight-raises-price-target-to-75
Needham Maintains Buy on RxSight, Raises P...
05/07/2024 11:12:45

Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and raises the price target from $64 to $75.

btig-maintains-buy-on-rxsight-raises-price-target-to-72
BTIG Maintains Buy on RxSight, Raises Pric...
05/07/2024 09:47:23

BTIG analyst Ryan Zimmerman maintains RxSight (NASDAQ:RXST) with a Buy and raises the price target from $61 to $72.

rxsight-raises-2024-revenue-guidance-from-128m-135m-to-132m-137m-vs-13155m-est
RxSight Raises 2024 Revenue Guidance From ...
05/06/2024 20:52:01

rxsight-q1-2024-adj-eps-012-beats-027-estimate-sales-29512m-beat-27559m-estimate
RxSight Q1 2024 Adj EPS $(0.12) Beats $(0....
05/06/2024 20:34:08

RxSight (NASDAQ:RXST) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.27) by 55...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
05/06/2024 20:31:06

stifel-maintains-buy-on-rxsight-raises-price-target-to-68
Stifel Maintains Buy on RxSight, Raises Pr...
05/06/2024 17:47:34

Stifel analyst Thomas Stephan maintains RxSight (NASDAQ:RXST) with a Buy and raises the price target from $64 to $68.

assessing-rxsight-insights-from-8-financial-analysts
Assessing RxSight: Insights From 8 Financi...
04/11/2024 12:00:19

needham-reiterates-buy-on-rxsight-maintains-64-price-target
Needham Reiterates Buy on RxSight, Maintai...
04/11/2024 09:55:38

Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $64 price target.

stifel-maintains-buy-on-rxsight-raises-price-target-to-64
Stifel Maintains Buy on RxSight, Raises Pr...
02/29/2024 17:46:47

Stifel analyst Thomas Stephan maintains RxSight (NASDAQ:RXST) with a Buy and raises the price target from $54 to $64.

jp-morgan-maintains-overweight-on-rxsight-raises-price-target-to-62
JP Morgan Maintains Overweight on RxSight,...
02/29/2024 16:28:58

JP Morgan analyst Robbie Marcus maintains RxSight (NASDAQ:RXST) with a Overweight and raises the price target from $40 to $62.

oppenheimer-maintains-outperform-on-rxsight-raises-price-target-to-61
Oppenheimer Maintains Outperform on RxSigh...
02/29/2024 15:50:05

Oppenheimer analyst Steven Lichtman maintains RxSight (NASDAQ:RXST) with a Outperform and raises the price target from $54 t...

forecasting-the-future-9-analyst-projections-for-rxsight
Forecasting The Future: 9 Analyst Projecti...
02/29/2024 13:00:37

needham-maintains-buy-on-rxsight-raises-price-target-to-64
Needham Maintains Buy on RxSight, Raises P...
02/29/2024 12:45:27

Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and raises the price target from $53 to $64.

rxsight-sees-fy24-revenue-128m-135m-vs-126957m-est
RxSight Sees FY24 Revenue $128M-$135M Vs $...
02/28/2024 22:16:21

recap-rxsight-q4-earnings
Recap: RxSight Q4 Earnings
02/28/2024 21:45:29

rxsight-q4-2023-adj-eps-013-beats-036-estimate-sales-2858m-beat-2743m-estimate
RxSight Q4 2023 Adj EPS $(0.13) Beats $(0....
02/28/2024 21:41:03

RxSight (NASDAQ:RXST) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.36) by 63...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION